Peripheral nerve dysfunction in patients with cystic fibrosis

Journal of Clinical Neurophysiology

Volumn 27, Issue 3, 2010, Pages 216-218

  El Salem, Khalid ^a   Aburahma, Samah ^a   Rawashdeh, Mohammad ^a  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

Author keywords

Cystic fibrosis; Nerve conduction studies; Peripheral nerves

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE ASSOCIATION; ELECTRODIAGNOSIS; FEMALE; HUMAN; LATENT PERIOD; MALE; MEDIAN NERVE; MOTOR NERVE; NERVE CONDUCTION; NERVE POTENTIAL; PERIPHERAL NEUROPATHY; PERONEUS NERVE; POLYNEUROPATHY; PRESCHOOL CHILD; SCHOOL CHILD; SENSORY NERVE; SURAL NERVE; ULNAR NERVE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; ELECTRIC STIMULATION; FEMALE; HUMANS; MALE; NEURAL CONDUCTION; PERIPHERAL NERVOUS SYSTEM DISEASES; REACTION TIME; YOUNG ADULT;

EID: 77953359382     PISSN: 07360258     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.WNP.0b013e3181e0a9f9     Document Type: Article

References (24)

1. Bines JE, Truby HD, Armstrong DS, et al. Vitamin A and E deficiency and lung disease in infants with cystic fibrosis. J Paediatr Child Health. 2005;41:663-668.
2. Botton E, Saraux A, Laselve H, et al. Musculoskeletal manifestations in cystic fibrosis. Joint Bone Spine. 2003;70:327-335. (Pubitemid 37243266)
3. Castellani C, Cuppens H, Macek M Jr, et al. Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. J Cyst Fibros. 2008;7:179-196.
4. Coffey M, Hassan J, Feighery C, et al. Rheumatoid factors in cystic fibrosis: association with disease manifestations and recurrent bacterial infections. Clin Exp Immunol. 1989;77:52-57.
5. Cynamon HA, Milov DE, Valenstein E, Wagner M. Effect of vitamin E deficiency on neurologic dysfunction in patients with cystic fibrosis. J Pediatr. 1988; 113:637-640.
6. Davies JC, Alton EW, Bush A. Cystic fibrosis. BMJ. 2007;335:1255-1259.
7. Dodge JA, Lewis PA, Stanton M, Wilsher J. Cystic fibrosis mortality and survival in the UK: 1947-2003. Eur Respir J 2007 29 522-526
8. Dsis ML, McDonald TL, Colombo JL, et al. Circulating immune complexes in cystic fibrosis and their correlation to clinical parameters. Pediatr Res. 1986;20:385-390.
9. Efthimiou J, Spickett G, Lane D, Thompson A. Antineutrophil cytoplasmic antibodies, cystic fibrosis, and infection. Lancet. 1991;337:1037-1038.
10. England JD, Gronseth GS, Franklin G, et al. Distal symmetric polyneuropathy: a definition for clinical research. Report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology. 2005;64:199-207.
11. Finnegan MJ, Hinchcliffe J, Russel-Jones D, et al. Vasculitis complicating cystic fibrosis. Q J Med. 1989;267:609-621.
12. Flume PA, Stenbit A. Making the diagnosis of cystic fibrosis. Am J Med Sci. 2008;335:51-54.
13. Fraser CM, Venter JC, Kaliner M. Autonomic abnormalities and autoantibodies to beta-adrenergic receptors. N Engl J Med. 1981;305:1165-1170.
14. Keogan MT, Callaghan M, Yanni G, et al. Spontaneous in vitro production of rheumatoid factor during infectious exacerbation of cystic fibrosis: correlation with circulating immune complex levels. Clin Exp Immunol. 1993;91: 462-466.
15. Kimura J. Electrodiagnosis in Diseases of Nerve and Muscle: Principles and Practice. 2nd ed. Philadelphia: FA Davis; 1989:103-128.
16. Massery M. Musculoskeletal and neuromuscular interventions: a physical approach to cystic fibrosis. J R Soc Med. 2005;98(Suppl. 45):55-66.
17. Mirakhur A, Walshaw MJ. Autonomic dysfunction in cystic fibrosis. J R Soc Med. 2003;96(suppl 43):11-17.
18. O'Riordan JI, Hayes J, Fitzgerald MX, Redmond J. Peripheral nerve dysfunction in adults with cystic fibrosis. Ir J Med Sci. 1995;164:207-208.
19. Riordan JR, Rommens JM, Kerem B, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989; 245:1066-1073. (Pubitemid 19231814)
20. Rosenstein BJ, Cutting GR; for the Cystic Fibrosis Foundation Consensus Panel. The diagnosis of cystic fibrosis: a consensus statement. J Pediatr. 1998;132: 589-595.
21. Rowe SM, Miller S, Sorscher EJ. Mechanisms of disease: cystic fibrosis. N Engl J Med. 2005;352:1992-2001.
22. Sokol RJ, Reardon MC, Accurso FJ, et al. Fat-soluble vitamins in infants identified by cystic fibrosis newborn screening. Pediatr Pulmonol Suppl. 1991;7:52-55.
23. Steinraths M, Vallance HD, Davidson AG. Delays in diagnosing cystic fibrosis: can we find ways to diagnose it earlier? Can Fam Physician. 2008;54:877-883.
24. Wulfraat NM, de Graeff-Meeder ER, Rijkers GT, et al. Prevalence of circulating immune complexes in patients with cystic fibrosis and arthritis. J Pediatr. 1994;125:374-378.